<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="UTF-8">
    <title>Healthcare Intelligence Report - SAMPLE</title>
    <link href="https://fonts.googleapis.com/css2?family=Playfair+Display:wght@400;600;700&family=Inter:wght@300;400;500;600&display=swap" rel="stylesheet">
    <style>
        * { margin: 0; padding: 0; box-sizing: border-box; }
        body { font-family: 'Inter', sans-serif; background: #F8F6F0; color: #2C2C2C; }
        
        .sample-banner {
            position: fixed;
            top: 0;
            left: 0;
            right: 0;
            background: linear-gradient(135deg, #FF6B6B, #E74C3C);
            color: white;
            padding: 15px;
            text-align: center;
            font-weight: 600;
            z-index: 10000;
            box-shadow: 0 4px 12px rgba(0,0,0,0.2);
        }
        
        .sidebar {
            position: fixed;
            left: 0;
            top: 60px;
            width: 280px;
            height: calc(100vh - 60px);
            background: #2C2C2C;
            color: white;
            padding: 40px 30px;
            overflow-y: auto;
        }
        
        .sidebar-logo {
            font-family: 'Playfair Display', serif;
            font-size: 28px;
            font-weight: 600;
            font-style: italic;
            margin-bottom: 10px;
            color: #E8C5D1;
        }
        
        .nav-section {
            margin-bottom: 30px;
        }
        
        .nav-section-title {
            font-size: 11px;
            text-transform: uppercase;
            letter-spacing: 0.15em;
            color: #666;
            margin-bottom: 12px;
            font-weight: 600;
        }
        
        .nav-link {
            display: block;
            padding: 10px 15px;
            color: #CCC;
            text-decoration: none;
            border-radius: 6px;
            transition: all 0.3s;
            font-size: 14px;
            margin-bottom: 5px;
        }
        
        .nav-link:hover {
            background: rgba(255,255,255,0.1);
            color: #E8C5D1;
            padding-left: 20px;
        }
        
        .nav-link.active {
            background: #E8C5D1;
            color: white;
            font-weight: 600;
        }
        
        .main-content {
            margin-left: 280px;
            padding: 100px 80px 60px;
            max-width: 1400px;
        }
        
        .page-section {
            background: white;
            padding: 60px;
            margin-bottom: 40px;
            border-radius: 12px;
            box-shadow: 0 4px 20px rgba(44, 44, 44, 0.06);
        }
        
        .page-title {
            font-family: 'Playfair Display', serif;
            font-size: 42px;
            margin-bottom: 15px;
        }
        
        .page-subtitle {
            font-size: 18px;
            color: #E8C5D1;
            margin-bottom: 40px;
        }
        
        h2 {
            font-family: 'Playfair Display', serif;
            font-size: 32px;
            margin: 40px 0 20px;
            color: #2C2C2C;
            border-bottom: 3px solid #E8C5D1;
            padding-bottom: 15px;
        }
        
        .metrics-grid {
            display: grid;
            grid-template-columns: repeat(auto-fit, minmax(250px, 1fr));
            gap: 30px;
            margin: 40px 0;
        }
        
        .metric-card {
            background: #F5F3ED;
            padding: 30px;
            border-radius: 12px;
            border-left: 4px solid #E8C5D1;
        }
        
        .metric-label {
            font-size: 13px;
            text-transform: uppercase;
            letter-spacing: 0.1em;
            color: #999;
            margin-bottom: 10px;
        }
        
        .metric-value {
            font-size: 36px;
            font-weight: 700;
            color: #E8C5D1;
            margin-bottom: 5px;
        }
        
        .metric-description {
            font-size: 14px;
            color: #666;
        }
        
        .alert-box {
            background: #FFEBEE;
            border-left: 4px solid #F44336;
            padding: 25px;
            margin: 30px 0;
            border-radius: 8px;
        }
        
        .alert-box h4 {
            color: #F44336;
            margin-bottom: 10px;
            font-size: 18px;
        }
        
        table {
            width: 100%;
            border-collapse: collapse;
            margin: 30px 0;
        }
        
        th {
            background: #2C2C2C;
            color: white;
            padding: 15px;
            text-align: left;
            font-weight: 600;
        }
        
        td {
            padding: 15px;
            border-bottom: 1px solid #E0E0E0;
        }
        
        .chart-placeholder {
            background: linear-gradient(135deg, #F5F3ED, #E8C5D1);
            height: 300px;
            border-radius: 12px;
            display: flex;
            align-items: center;
            justify-content: center;
            margin: 30px 0;
            font-size: 14px;
            color: #666;
        }
    </style>
</head>
<body>
    <div class="sample-banner">
         SAMPLE REPORT - This is an example of what your actual report will contain with your real data
    </div>

    <div class="sidebar">
        <div class="sidebar-logo">ROUZE</div>
        <p style="font-size: 12px; color: #999; margin-bottom: 30px;">Healthcare Intelligence</p>
        
        <div class="nav-section">
            <div class="nav-section-title">Overview</div>
            <a href="#executive-summary" class="nav-link active">Executive Summary</a>
            <a href="#risk-score" class="nav-link">Risk Score</a>
            <a href="#recommendation" class="nav-link">Recommendation</a>
        </div>
        
        <div class="nav-section">
            <div class="nav-section-title">Signal Analysis</div>
            <a href="#adverse-events" class="nav-link">Adverse Event Detection</a>
            <a href="#patient-forums" class="nav-link">Patient Forum Analysis</a>
            <a href="#statistical" class="nav-link">Statistical Validation</a>
        </div>
        
        <div class="nav-section">
            <div class="nav-section-title">Regulatory Intelligence</div>
            <a href="#fda-risk" class="nav-link">FDA Action Probability</a>
            <a href="#timeline" class="nav-link">Regulatory Timeline</a>
            <a href="#cost-analysis" class="nav-link">Cost-Benefit Analysis</a>
        </div>
        
        <div class="nav-section">
            <div class="nav-section-title">Competitive</div>
            <a href="#competitive" class="nav-link">Competitor Analysis</a>
            <a href="#market-impact" class="nav-link">Market Impact</a>
        </div>
    </div>

    <div class="main-content">
        <div class="page-section" id="executive-summary">
            <div class="page-title">Adverse Event Intelligence Report</div>
            <div class="page-subtitle">Drug XYZ-123 Safety Signal Analysis</div>
            
            <h2>Executive Summary</h2>
            
            <div class="metrics-grid">
                <div class="metric-card">
                    <div class="metric-label">Overall Risk Score</div>
                    <div class="metric-value">78/100</div>
                    <div class="metric-description">High priority - immediate action recommended</div>
                </div>
                
                <div class="metric-card">
                    <div class="metric-label">Signal Strength</div>
                    <div class="metric-value">14.3%</div>
                    <div class="metric-description">Adverse event rate vs 4.2% baseline (p<0.001)</div>
                </div>
                
                <div class="metric-card">
                    <div class="metric-label">Patient Signals Analyzed</div>
                    <div class="metric-value">3,247</div>
                    <div class="metric-description">Across 12 sources over 180 days</div>
                </div>
                
                <div class="metric-card">
                    <div class="metric-label">FDA Action Probability</div>
                    <div class="metric-value">68%</div>
                    <div class="metric-description">Within 12 months based on signal trajectory</div>
                </div>
            </div>
            
            <div class="alert-box">
                <h4> HIGH PRIORITY: Proactive Label Update Recommended</h4>
                <p>
                    Statistical analysis of 3,247 patient-reported adverse events across patient forums, social media, 
                    and medical communities reveals significant elevation in cardiovascular symptoms (14.3% vs 4.2% 
                    baseline, p<0.001). This signal emerged 6-9 months before expected FDA MAUDE reporting lag. 
                    Proactive label update estimated to prevent $650K reactive compliance costs and preserve physician confidence.
                </p>
            </div>
            
            <h2>Key Findings</h2>
            <ul style="line-height: 2; margin-left: 20px;">
                <li><strong>Adverse Event Pattern Detected:</strong> Cardiovascular symptoms occurring in 14.3% of patient-reported cases (vs 4.2% baseline FDA data)</li>
                <li><strong>Statistical Significance:</strong> Chi-square test p<0.001 indicates <0.1% probability this pattern is random noise</li>
                <li><strong>Early Warning Advantage:</strong> Signal detected 180 days before expected FDA MAUDE database reflection</li>
                <li><strong>Patient Forum Sentiment:</strong> Negative sentiment increasing 23% month-over-month in cardiovascular discussions</li>
                <li><strong>Competitive Intelligence:</strong> No competitor drugs in class showing similar pattern (defensive positioning opportunity)</li>
            </ul>
        </div>

        <div class="page-section" id="adverse-events">
            <h2>Adverse Event Signal Detection</h2>
            
            <h3>Data Sources Analyzed</h3>
            <table>
                <tr>
                    <th>Source Type</th>
                    <th>Signals Collected</th>
                    <th>Time Period</th>
                    <th>Quality Score</th>
                </tr>
                <tr>
                    <td>Patient Forums (Drugs.com, WebMD)</td>
                    <td>1,247 reports</td>
                    <td>180 days</td>
                    <td>High (verified users)</td>
                </tr>
                <tr>
                    <td>Social Media (Twitter, Reddit r/AskDocs)</td>
                    <td>892 mentions</td>
                    <td>180 days</td>
                    <td>Medium (unverified)</td>
                </tr>
                <tr>
                    <td>Medical Professional Forums</td>
                    <td>420 discussions</td>
                    <td>180 days</td>
                    <td>Very High (MD-verified)</td>
                </tr>
                <tr>
                    <td>Clinical Trial Recruitment Sites</td>
                    <td>340 mentions</td>
                    <td>180 days</td>
                    <td>High (structured data)</td>
                </tr>
                <tr>
                    <td>FDA MAUDE Database (baseline)</td>
                    <td>348 reports</td>
                    <td>360 days (lag)</td>
                    <td>Very High (official)</td>
                </tr>
            </table>
            
            <h3>Temporal Pattern Analysis</h3>
            <div class="chart-placeholder">
                ðŸ“Š Interactive Chart: Adverse Event Frequency Over Time
                <br>Your actual report includes interactive Plotly charts showing signal emergence
            </div>
            
            <h3>Statistical Validation</h3>
            <div style="background: #F5F3ED; padding: 30px; border-radius: 12px; margin: 30px 0;">
                <h4 style="margin-bottom: 15px;">Chi-Square Test Results</h4>
                <p><strong>Null Hypothesis:</strong> Observed adverse event rate equals baseline rate (4.2%)</p>
                <p><strong>Observed Rate:</strong> 14.3% (465 events / 3,247 patient reports)</p>
                <p><strong>Expected Rate:</strong> 4.2% (136 events expected at baseline)</p>
                <p><strong>Chi-Square Statistic:</strong> Ï‡Â² = 187.3</p>
                <p><strong>P-value:</strong> p < 0.001</p>
                <p><strong>Effect Size (Cohen's h):</strong> 0.62 (medium-large effect)</p>
                <p style="margin-top: 20px; color: #E74C3C; font-weight: 600;">
                    Conclusion: Less than 0.1% probability this pattern occurred by chance. Signal is statistically robust.
                </p>
            </div>
        </div>

        <div class="page-section" id="fda-risk">
            <h2>FDA Action Probability Assessment</h2>
            
            <h3>Regulatory Risk Scoring Model</h3>
            <p>
                Based on historical FDA enforcement patterns for similar adverse event signals, we model the probability 
                of regulatory action within specific timeframes.
            </p>
            
            <table>
                <tr>
                    <th>Timeframe</th>
                    <th>Action Type</th>
                    <th>Probability</th>
                    <th>Expected Cost (Reactive)</th>
                </tr>
                <tr>
                    <td>0-6 months</td>
                    <td>FDA Information Request</td>
                    <td>35%</td>
                    <td>$45K (response preparation)</td>
                </tr>
                <tr>
                    <td>6-12 months</td>
                    <td>Safety Communication Required</td>
                    <td>68%</td>
                    <td>$180K (emergency protocol)</td>
                </tr>
                <tr>
                    <td>12-18 months</td>
                    <td>Mandatory Label Change</td>
                    <td>42%</td>
                    <td>$650K (reactive compliance)</td>
                </tr>
                <tr>
                    <td>18+ months</td>
                    <td>Black Box Warning</td>
                    <td>12%</td>
                    <td>$2.3M+ (market impact)</td>
                </tr>
            </table>
            
            <h3>Proactive vs Reactive Cost Analysis</h3>
            <div class="metrics-grid">
                <div class="metric-card" style="border-left-color: #4CAF50;">
                    <div class="metric-label">Proactive Label Update (Now)</div>
                    <div class="metric-value" style="color: #4CAF50;">$120K</div>
                    <div class="metric-description">Voluntary update, controlled timeline, maintain physician confidence</div>
                </div>
                
                <div class="metric-card" style="border-left-color: #E74C3C;">
                    <div class="metric-label">Reactive Response (12mo)</div>
                    <div class="metric-value" style="color: #E74C3C;">$650K</div>
                    <div class="metric-description">Emergency compliance, reputation damage, market share loss</div>
                </div>
            </div>
            
            <div style="background: #E8F5E9; padding: 30px; border-radius: 12px; border-left: 4px solid #4CAF50; margin: 30px 0;">
                <h4 style="color: #4CAF50; margin-bottom: 15px;"> Strategic Recommendation</h4>
                <p>
                    Expected value analysis: Proactive action saves $530K in avoided reactive costs (68% probability Ã— $650K 
                    reactive - $120K proactive). Additionally preserves competitive positioning by demonstrating safety 
                    leadership rather than reactive compliance.
                </p>
            </div>
        </div>

        <div class="page-section" id="competitive">
            <h2>Competitive Intelligence</h2>
            
            <h3>Competitor Safety Profile Comparison</h3>
            <table>
                <tr>
                    <th>Drug</th>
                    <th>Company</th>
                    <th>Similar AE Pattern?</th>
                    <th>Market Share</th>
                    <th>Strategic Implication</th>
                </tr>
                <tr>
                    <td>Competitor Drug A</td>
                    <td>Pharma Co 1</td>
                    <td>No (4.1% rate)</td>
                    <td>32%</td>
                    <td>Competitive vulnerability if they have similar unreported signals</td>
                </tr>
                <tr>
                    <td>Competitor Drug B</td>
                    <td>Pharma Co 2</td>
                    <td>No (3.8% rate)</td>
                    <td>28%</td>
                    <td>Potential positioning advantage through safety transparency</td>
                </tr>
                <tr>
                    <td>Competitor Drug C</td>
                    <td>Pharma Co 3</td>
                    <td>Unknown</td>
                    <td>19%</td>
                    <td>Monitor for similar pattern emergence</td>
                </tr>
            </table>
            
            <h3>Competitive Positioning Opportunity</h3>
            <p>
                Analysis of competitor safety communications reveals no major players have proactively disclosed 
                cardiovascular signals in this drug class. Voluntary transparency positions your drug as safety leader, 
                potentially converting competitor concerns into market share gain.
            </p>
        </div>

        <div style="margin-top: 80px; padding: 40px 60px; background: #2C2C2C; border-radius: 12px; color: white; text-align: center;">
            <div style="font-family: 'Playfair Display', serif; font-size: 32px; font-style: italic; margin-bottom: 15px; color: #E8C5D1;">
                ROUZE
            </div>
            <div style="font-size: 14px; text-transform: uppercase; letter-spacing: 0.15em; color: #999; margin-bottom: 25px;">
                Healthcare Intelligence
            </div>
            <p style="font-size: 14px; line-height: 1.8; color: #CCC; max-width: 600px; margin: 0 auto;">
                This sample demonstrates the depth and rigor of Rouze healthcare intelligence reports. 
                Your actual report will contain your specific drug data, customized analysis, and actionable recommendations 
                based on real-time signal monitoring across 15+ data sources.
            </p>
            <div style="margin-top: 30px;">
                <a href="/intake/healthcare" style="display: inline-block; background: #E8C5D1; color: white; padding: 14px 35px; border-radius: 50px; text-decoration: none; font-weight: 600; text-transform: uppercase; letter-spacing: 0.05em;">
                    Request Your Analysis
                </a>
            </div>
        </div>
    </div>
</body>
</html>
